Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Latest action (6 Mar 2020): Became Public Law No: 116-123.
What this bill does
H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, provides additional funding for federal agencies to address the coronavirus. Specifically, it allocates funds for the Food and Drug Administration, the Small Business Administration, the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Department of State. These funds are intended for a range of activities, including medical research and development, vaccine and therapeutic purchases, supply chain monitoring, disaster loans for businesses, and international response efforts.
The bill directly affects government agencies responsible for public health, economic stability, and international relations. It aims to equip these agencies with the financial resources needed to prevent, prepare for, and respond to the coronavirus outbreak. For example, a significant portion of the funds is designated for the CDC to support states and localities in surveillance, laboratory capacity, and other preparedness activities. Small businesses impacted by the outbreak may also benefit from increased resources for disaster loans through the Small Business Administration.
This bill originated in the House of Representatives and was introduced on March 4, 2020. Following its passage, it was signed into law by the President on March 6, 2020, making it an enacted law. As an enacted law, its provisions are now in effect and the appropriated funds can be utilized by the designated agencies.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
This bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak.
DIVISION A--CORONAVIRUS PREPAREDNESS AND RESPONSE SUPPLEMENTAL APPROPRIATIONS ACT, 2020
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
This division provides FY2020 supplemental appropriations for the Department of Health and Human Services (HHS), the State Department, and the Small Business Administration to respond to the coronavirus outbreak.
The division funds programs that address issues such as
• developing, manufacturing, and procuring vaccines and other medical supplies;
• grants for state, local, and tribal public health agencies and organizations;
Timeline
6 Mar 2020
Became Public Law No: 116-123.
Common questions
- What does H.R. 6074 do?
- H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, provides additional funding for federal agencies to address the coronavirus. Specifically, it allocates funds for the Food and Drug Administration, the Small Business Administration, the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Department of State. These funds are intended for a range of activities, including medical research and development, vaccine and therapeutic purchases, supply chain monitoring, disaster loans for businesses, and international response efforts. The bill directly affects government agencies responsible for public health, economic stability, and international relations. It aims to equip these agencies with the financial resources needed to prevent, prepare for, and respond to the coronavirus outbreak. For example, a significant portion of the funds is designated for the CDC to support states and localities in surveillance, laboratory capacity, and other preparedness activities. Small businesses impacted by the outbreak may also benefit from increased resources for disaster loans through the Small Business Administration. This bill originated in the House of Representatives and was introduced on March 4, 2020. Following its passage, it was signed into law by the President on March 6, 2020, making it an enacted law. As an enacted law, its provisions are now in effect and the appropriated funds can be utilized by the designated agencies.
- Has H.R. 6074 become law?
- Yes. H.R. 6074 has been enacted. Status last updated 6 Mar 2020.
- Who sponsored H.R. 6074?
- H.R. 6074 was sponsored by Rep. Lowey, Nita M. [D-NY-17] (D-NY), with 0 cosponsors.
- What's the latest action on H.R. 6074?
- Became Public Law No: 116-123. (6 Mar 2020).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Lowey, Nita M. [D-NY-17]
American Coronavirus/COVID–19 Election Safety and Security Act
Antitrust Criminal Penalty Enhancement and Reform Permanent Extension Act
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2021
Scientific Integrity Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.